🇺🇸 AUTOLOGOUS CULTURED CHONDROCYTES in United States

8 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 1 report (12.5%)
  2. Asthenia — 1 report (12.5%)
  3. Blood Pressure Abnormal — 1 report (12.5%)
  4. Dizziness — 1 report (12.5%)
  5. Fatigue — 1 report (12.5%)
  6. Insomnia — 1 report (12.5%)
  7. Myalgia — 1 report (12.5%)
  8. Vision Blurred — 1 report (12.5%)

Source database →

AUTOLOGOUS CULTURED CHONDROCYTES in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is AUTOLOGOUS CULTURED CHONDROCYTES approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for AUTOLOGOUS CULTURED CHONDROCYTES in United States?

Marketing authorisation holder not available in our data.